| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The D.I. Ivanovsky Institute of Virology, U.S.S.R. Academy of Medical Sciences, Moscow, U.S.S.R.
Uncoating of influenza virus (strain WSN) in MDCK cells was studied by following the fate of the virus labelled with radioactive precursors. The accumulation of subviral components of input virus was observed in nuclear-associated cytoplasm (NAC) obtained by treatment of the nuclei with citric acid. Two types of subviral components were found there, ribonucleoproteins (RNPs) and larger subviral particles (SVP) containing RNPs in association with M protein. SVP, with different relative amounts of M protein, were revealed in NAC, suggesting that M protein was gradually released from RNPs. The released RNPs entered the nuclei while M protein accumulated within perinuclear membranes. Thus, SVP could be regarded as probable intermediates in virus uncoating. Rimantadine prevented the release of M protein from RNPs and their penetration into the nuclei provoking the accumulation of subviral components in NAC.
Keywords: influenza virus, uncoating, rimantadine, RNPs
Received 20 July 1981;
accepted 7 December 1981.
This article has been cited by other articles:
|
|
 |
|
  M. F. McCown and A. Pekosz Distinct domains of the influenza a virus m2 protein cytoplasmic tail mediate binding to the m1 protein and facilitate infectious virus production. J. Virol., August 1, 2006; 80(16): 8178 - 8189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. McCown and A. Pekosz The Influenza A Virus M2 Cytoplasmic Tail Is Required for Infectious Virus Production and Efficient Genome Packaging J. Virol., March 15, 2005; 79(6): 3595 - 3605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Imai, S. Watanabe, A. Ninomiya, M. Obuchi, and T. Odagiri Influenza B Virus BM2 Protein Is a Crucial Component for Incorporation of Viral Ribonucleoprotein Complex into Virions during Virus Assembly J. Virol., October 15, 2004; 78(20): 11007 - 11015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jegerlehner, N. Schmitz, T. Storni, and M. F. Bachmann Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity J. Immunol., May 1, 2004; 172(9): 5598 - 5605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tang, F. Zaitseva, R. A. Lamb, and L. H. Pinto The Gate of the Influenza Virus M2 Proton Channel Is Formed by a Single Tryptophan Residue J. Biol. Chem., October 11, 2002; 277(42): 39880 - 39886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takeda, A. Pekosz, K. Shuck, L. H. Pinto, and R. A. Lamb Influenza A Virus M2 Ion Channel Activity Is Essential for Efficient Replication in Tissue Culture J. Virol., February 1, 2002; 76(3): 1391 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. N. Root, E. G. Wills, L. L. McNair, and G. R. Whittaker Entry of influenza viruses into cells is inhibited by a highly specific protein kinase C inhibitor J. Gen. Virol., November 1, 2000; 81(11): 2697 - 2705. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. Plotch, B. O'Hara, J. Morin, O. Palant, J. LaRocque, J. D. Bloom, S. A. Lang Jr., M. J. DiGrandi, M. Bradley, R. Nilakantan, et al. Inhibition of Influenza A Virus Replication by Compounds Interfering with the Fusogenic Function of the Viral Hemagglutinin J. Virol., January 1, 1999; 73(1): 140 - 151. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
